Overview
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is committed to advancing clinical and translational science to develop new therapies and treatments and improve health and health care in New Jersey. A consortium coordinated by Rutgers Biomedical and Health Sciences, NJ ACTS includes Rutgers and Princeton Universities, NJ Institute for Technology (NJIT), medical, nursing, dental and public health schools, hospitals, community health centers, outpatient practices, industry, policymakers and health information exchanges. A unique combination of institutions, NJ ACTS is committed to community engagement, ensuring that New Jersyans are partners in our research through patient advocacy and community partnerships.
NJ ACTS supports clinical and translational research, broadly defined, by providing services, expertise, and financial resources; facilitates collaboration among partners; provides training and workforce development; and improves the public’s understanding of science and research.
What is a CTSA?
5 Goals:
• Train and Cultivate Translational Science Workforce
• Engage Patients and Communities
• Integrate Special and Underserved Populations in CTS Across the Lifespan
• Increase the Quality and Efficiency of CTS Research, esp. Multi-site Trials
• Advance the Use of Cutting Edge Informatics
What/Who is NJ ACTS?
NJ ACTS is:
• An alliance of NJ academic institutions Rutgers University, Princeton University and the New Jersey
Institute of Technology with partners from industry, clinical, state, and community
• Formed with an initial $29 million in National Institutes of Health (NIH) funding in 2019
• In 2024, The National Institutes of Health (NIH) awarded NJACTS $40 million over seven years to build and improve upon infrastructure that promotes clinical and translational
science
• Based in the Rutgers Institute for Translational Medicine and Science (RITMS)
• NIH Components of original 5 year grant:
– Hub award (UL1)
– Institutional Career Development Award (KL2)
– Institutional Training Award (TL1) Institute for Translational Medicine and Science
NIH Components of 7 year grant extension
– Hub award (UM1)
– Institutional Career Development Award (K12)
– Institutional Training Award (T32) Institute for Translational Medicine and Science